PrimeRFP SCOUT · Federal Contract Recompete Brief

36C25023D0021Radiopharmaceutical DRUGS EO 14398 — Schaaf Drugs, LLC

Schaaf Drugs, LLC holds $3.7M across 18 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards in the incumbent pipeline. Set-aside status: NONE.

250-Network Contract Office 10 (36C250)

Awarding office

Schaaf Drugs, LLC

Recipient

—

Estimated value

6505

PSC

NONE

Set-aside

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Schaaf Drugs, LLC — $90

Contract facts

NONE

Contract number36C25023D0021

Also listed as36C250-23-D-0021

Agency250-Network Contract Office 10 (36C250)

Awarding office250-Network Contract Office 10 (36C250)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentSchaaf Drugs, LLC

UEILSEHGNVLAVX5

PSC6505

RADIOPHARMACEUTICAL DRUGS EO 14398 is a federal NONE award for 250-Network Contract Office 10 (36C250) held by Schaaf Drugs, LLC. Estimated value —.

Incumbent footprint

Public record

Schaaf Drugs, LLC — $3.7M obligated across 18 awards (firm-wide, all agencies).

Sole agency: Department of Veterans Affairs (VA)

Department of Veterans Affairs (VA)$3.7M · 100% of firm total

Open full company profile →

Related awards

Same incumbent

36C25026N0022

EXERCISING FINAL OY

$3.9M

Sep 30, 2026

36C25025F0010

ORDERING PERIOD OBLIGATION

$2.9M

Sep 30, 2026

36C25023N0050

EXERCISE ORDERING PERIOD 2 RPOC LINE ITEM COMPLIANCE RADIOPHARM FOR THE DAYTON VAMC

$1.3M

Sep 30, 2026

36C25022N0012

RADIOPHARM

$646K

Sep 30, 2026

36C25026N0181

YEAR 4, OPTION YEAR 3 PATIENT RADIOPHARMACEUTICAL DRUGS (12 MONTHS)

$681K

Nov 22, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C25023D0021?

36C25023D0021 (Radiopharmaceutical DRUGS EO 14398) is a 250-Network Contract Office 10 (36C250) award with an estimated value of —, currently held by Schaaf Drugs, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C250-23-D-0021?

36C250-23-D-0021 is the dashed form of PIID 36C25023D0021 (Radiopharmaceutical DRUGS EO 14398), held by Schaaf Drugs, LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C25023D0021?

250-Network Contract Office 10 (36C250) awarded 36C25023D0021 to Schaaf Drugs, LLC.

Who is the incumbent on 36C25023D0021?

Schaaf Drugs, LLC is the incumbent with $3.7M across 18 related awards in SCOUT’s public footprint.

When does Schaaf Drugs, LLC’s 36C25023D0021 come up for recompete?

SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 25, 2026 · refreshed monthly